AGM/EGMJul 28, 2026, 04:32 PM
Grace Therapeutics to Hold 2026 Annual Meeting on September 17
AI Summary
Grace Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on September 17, 2026, at 8:30 a.m. Eastern Time. Shareholders of record as of July 20, 2026, will vote on the election of five director nominees, an advisory resolution on executive compensation, the ratification of KPMG LLP as the independent auditor, and the frequency of future advisory votes on executive compensation. The Board recommends voting for all proposals and for an annual frequency for executive compensation votes.
Key Highlights
- 2026 Annual Meeting scheduled for September 17, 2026, at 8:30 a.m. ET.
- Meeting will be held virtually at www.virtualshareholdermeeting.com/GRCE2026.
- Shareholders of record as of July 20, 2026, are eligible to vote.
- Proposals include electing five director nominees for a one-year term.
- Advisory vote on named executive officer compensation.
- Ratification of KPMG LLP as independent auditor for fiscal year ending March 31, 2027.
- Advisory vote on frequency of future executive compensation votes (Board recommends 1 year).
- 16,274,026 shares of common stock outstanding on the Record Date.
Price Impact
More from GRCE